Monthly Archives: March 2013

“ALL ROADS LEAD TO EASTERN”

As a member of the first Companies for Causes business cohort whose focus is currently “to support Eastern Senior High School’s Legacy Class of 2015 graduate high school,” we realize that long-term, ultimate “success at Eastern” requires a much more … Continue reading

Posted in Consulting, CSR | Tagged , | Leave a comment

Nonprofit Fraud Seminar Series

The Raffa Learning Community is hosting a special three-part series of free seminars on how to detect and prevent common fraud schemes perpetrated against nonprofit organizations. Update: As of March 27th, registration for Part I of the series is full. If … Continue reading

Posted in Accounting, Audit, Consulting, Forensic Accounting, Learning Community | Leave a comment

Markets Ended the Week on an Uptick

Financial News for the Week Ending March 23rd The U.S. market ended the week on an uptick as investors grew more confident that a deal would be reached with Cyprus.  However, for the week, the S&P 500 fell 0.2% and … Continue reading

Posted in Investment Advisory | Leave a comment

Dow Had 1st Down Day in 10 Sessions

Financial News for the Week Ending March 16th The Dow had its first down day in ten sessions on Friday, but the index rose 0.8% for the week. The S&P 500 also gained 0.6% and is just 0.28% short of … Continue reading

Posted in Investment Advisory | Tagged | Leave a comment

Dow Completes Its Comeback

Financial News for the Week Ending March 9th The Dow has completed its comeback from the financial crisis and set a new all-time high on Tuesday and each day after. It ended the week at the all time high of … Continue reading

Posted in Investment Advisory | Tagged | Leave a comment

Markets Shrugged Off the Sequester

Financial News for the Week Ending March 2nd After starting the week with their worst day of the year on the news of Italian election results that could bring about instability, U.S. stocks rebounded to finish up 0.2%. Markets largely … Continue reading

Posted in Investment Advisory | Tagged | Leave a comment